The excess of the baby’s weight with an aggressive reaction to the leukemia can be worsened with immunotherapy. This is reported by the Dutch Prinses Máxima Centrum on the basis of new information that is published this week in the ‘New England Journal of Medicine’. Volgens het Centrum in Utrecht was pediatric oncological expertise concentrated, word immunotherapy with het geneesmiddel blinatumomab nu wereldwijd standard.
ttn-39
Onderzoek: Overlevingskans baby’s with aggressive leukemia worse with immunotherapy
